Pharmacokinetic-pharmacodynamic modelling of neutrophil response to G-CSF in healthy subjects and patients with chemotherapy-induced neutropenia.

about

Pharmacokinetic-pharmacodynamic modelling of neutrophil response to G-CSF in healthy subjects and patients with chemotherapy-induced neutropenia.

Item

http://www.wikidata.org/entity/Q48273553

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Pharmacokinetic-pharmacodynami ...... motherapy-induced neutropenia.

@en

Pharmacokinetic-pharmacodynami ...... motherapy-induced neutropenia.

@nl

type

Item

label

Pharmacokinetic-pharmacodynami ...... motherapy-induced neutropenia.

@en

Pharmacokinetic-pharmacodynami ...... motherapy-induced neutropenia.

@nl

prefLabel

Pharmacokinetic-pharmacodynami ...... motherapy-induced neutropenia.

@en

Pharmacokinetic-pharmacodynami ...... motherapy-induced neutropenia.

@nl

P1476

Pharmacokinetic-pharmacodynami ...... emotherapy-induced neutropenia

@en

P2093

Andrew Chow

http://www.w3.org/2001/XMLSchema#string

Isabelle Delor

http://www.w3.org/2001/XMLSchema#string

John Harrold

http://www.w3.org/2001/XMLSchema#string

Juan Jose Pérez-Ruixo

http://www.w3.org/2001/XMLSchema#string

Liviawati Wu

http://www.w3.org/2001/XMLSchema#string

Philippe Jacqmin

http://www.w3.org/2001/XMLSchema#string

P2860

Three different mRNAs encoding human granulocyte colony-stimulating factor receptor

Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models.

Towards Quantitative Systems Pharmacology Models of Chemotherapy-Induced Neutropenia.

Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?

Neutrophil kinetics in health and disease.

Pharmacodynamics-mediated drug disposition (PDMDD) and precursor pool lifespan model for single dose of romiplostim in healthy subjects.

The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo.

2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.

Modelling chemotherapy effects on granulopoiesis.

XM02 is superior to placebo and equivalent to Neupogen in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy.

P304

911-925

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.13504

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Murad Melhem

P577

2018-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29318653

http://www.w3.org/2001/XMLSchema#string

P932

5903247

http://www.w3.org/2001/XMLSchema#string